SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021)

被引：4

作者：

Martinez-Garcia, Maria ^{[1
,2
]}

Servitja Tormo, Sonia ^{[1
]}

Vilarino Quintela, Noelia ^{[3
]}

Arance Fernandez, Ana ^{[4
]}

Berrocal Jaime, Alfonso ^{[5
]}

Cantos Sanchez de Ibarguen, Blanca ^{[6
]}

Del Barco Berron, Sonia ^{[7
]}

Garcia Campelo, Rosario ^{[8
]}

Girones Sarrio, Regina ^{[9
]}

Manuel Sepulveda-Sanchez, Juan ^{[10
]}

机构：

[1] Hosp Mar, Dept Med Oncol, Barcelona, Spain

[2] CIOCC HM Delfos, Barcelona, Spain

[3] Inst Catala Oncol L Hosp, Dept Med Oncol, Barcelona, Spain

[4] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[5] Consorcio Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain

[6] Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain

[7] Hosp Univ Dr Josep Trueta, Dept Med Oncol, ICO, Girona, Spain

[8] Complexo Hosp Univ A Coruna CHUAC, Dept Med Oncol, La Coruna, Spain

[9] Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain

[10] Hosp Univ, Dept Med Oncol, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2022年 / 24卷 / 04期

关键词：

Brain metastasis; Blood-brain barrier; Targeted therapies; Immunotherapy; Guidelines; CELL LUNG-CANCER; NEGATIVE BREAST-CANCER; OPEN-LABEL; MUTANT MELANOMA; FOLLOW-UP; CRIZOTINIB; CHEMOTHERAPY; MULTICENTER; SURVIVAL; DABRAFENIB;

D O I：

10.1007/s12094-022-02803-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the most common types of malignant intracranial tumors and are reported in approximately 25% of patients with metastatic cancers. The recent increase in incidence of BMs is due to several factors including better diagnostic assessments and the development of improved systemic therapies that have lower activity on the CNS. However, newer systemic therapies are being developed that can cross the blood-brain barrier giving us additional tools to treat BMs. The guidelines presented here focus on the efficacy of new targeted systemic therapies and immunotherapies on CNS BMs from breast, melanoma, and lung cancers.

引用

页码：703 / 711

页数：9

共 50 条

[21] Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
Camidge, D. Ross
Lee, Eudocia Q.
Lin, Nancy U.
Margolin, Kim
Ahluwalia, Manmeet S.
Bendszus, Martin
Chang, Susan M.
Dancey, Janet
de Vries, Elisabeth G. E.
Harris, Gordon J.
Hodi, F. Stephen
Lassman, Andrew B.
Macdonald, David R.
Peereboom, David M.
Schiff, David
Soffietti, Ricardo
van den Bent, Martin J.
Wefel, Jeffrey S.
Wen, Patrick Y.
LANCET ONCOLOGY, 2018, 19 (01) : E20 - E32
[22] Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs
Leong, Tiffany W.
Pal, Arindam
Cai, Qi
Gao, Zhenghong
Li, Xiaoqing
Bleris, Leonidas
Hayenga, Heather N.
Qin, Zhenpeng
JOURNAL OF CONTROLLED RELEASE, 2023, 357 : 511 - 530
[23] The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Gaspar, Laurie E.
Mehta, Minesh P.
Patchell, Roy A.
Burri, Stuart H.
Robinson, Paula D.
Morris, Rachel E.
Ammirati, Mario
Andrews, David W.
Asher, Anthony L.
Cobbs, Charles S.
Kondziolka, Douglas
Linskey, Mark E.
Loeffler, Jay S.
McDermott, Michael
Mikkelsen, Tom
Olson, Jeffrey J.
Paleologos, Nina A.
Ryken, Timothy C.
Kalkanis, Steven N.
JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (01) : 17 - 32
[24] Impact of Systemic and Radiation Therapy on Survival of Primary Central Nervous System Lymphoma
Janopaul-Naylor, James Robert
Patel, Jimmy S.
Rupji, Manali
Hoang, Kimberly Bojanowski
Mccall, Neal Sean
Qian, David C.
Shoaf, Madison Lee
Kothari, Shawn
Olson, Jeffrey J.
Shu, Hui-Kuo G.
Voloschin, Alfredo
Zhong, Jim
Neill, Stewart G.
Eaton, Bree
CANCERS, 2025, 17 (04)
[25] Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies
Gautam, Avtar Singh
Pandey, Shivam Kumar
Lasure, Vaibhav
Dubey, Sachin
Singh, Rakesh Kumar
EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (07) : 603 - 618
[26] The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline
Ammirati, Mario
Cobbs, Charles S.
Linskey, Mark E.
Paleologos, Nina A.
Ryken, Timothy C.
Burri, Stuart H.
Asher, Anthony L.
Loeffler, Jay S.
Robinson, Paula D.
Andrews, David W.
Gaspar, Laurie E.
Kondziolka, Douglas
McDermott, Michael
Mehta, Minesh P.
Mikkelsen, Tom
Olson, Jeffrey J.
Patchell, Roy A.
Kalkanis, Steven N.
JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (01) : 85 - 96
[27] Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer
Warren, Laura E. G.
Niman, Samuel M.
Remolano, Marie C.
Landry, Jean M.
Nakhlis, Faina
Bellon, Jennifer R.
Aizer, Ayal A.
Lin, Nancy U.
Tolaney, Sara M.
Regan, Meredith M.
Overmoyer, Beth A.
Lynce, Filipa
CANCER, 2022, 128 (23) : 4085 - 4094
[28] Central Nervous System Systemic Lupus Erythematosus: Pathophysiologic, Clinical, and Imaging Features
Ota, Yoshiaki
Srinivasan, Ashok
Capizzano, Aristides A.
Bapuraj, Jayapalli R.
Kim, John
Kurokawa, Ryo
Baba, Akira
Moritani, Toshio
RADIOGRAPHICS, 2022, 42 (01) : 212 - 232
[29] The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Mehta, Minesh P.
Paleologos, Nina A.
Mikkelsen, Tom
Robinson, Paula D.
Ammirati, Mario
Andrews, David W.
Asher, Anthony L.
Burri, Stuart H.
Cobbs, Charles S.
Gaspar, Laurie E.
Kondziolka, Douglas
Linskey, Mark E.
Loeffler, Jay S.
McDermott, Michael
Olson, Jeffrey J.
Patchell, Roy A.
Ryken, Timothy C.
Kalkanis, Steven N.
JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (01) : 71 - 83
[30] The role of radiation therapy in the management of primary central nervous system lymphoma
Milgrom, Sarah A.
Yahalom, Joachim
LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1197 - 1204

← 1 2 3 4 5 →